Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Disease-modifying drugs in multiple sclerosis.

Elizabeth Keenan1, Bernadette Porter

  • 1National Hospital for Neurology and Neurosurgery, UCLH Trust, London. elizabeth.keenan@uclh.org

Nursing Standard (Royal College of Nursing (Great Britain) : 1987)
|October 3, 2003
PubMed
Summary

This article details the development of a disease-modifying drug (DMD) treatment service for multiple sclerosis (MS). It offers practical insights for MS nurses establishing and managing DMD clinics to ensure best practice and patient care.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Leading across boundaries: establishment of the UCLH community outreach intrathecal baclofen refill service.

BMJ open quality·2026
Same author

The prevention and management of hospital admissions for urinary tract infection in patients with multiple sclerosis.

Multiple sclerosis and related disorders·2020
Same author

Screening for urinary tract colonisation prior to corticosteroid administration in acute multiple sclerosis relapses: Validation of an updated algorithm.

Journal of the neurological sciences·2019
Same author

Commentary on "Localized pigmentation disorder after subcutaneous pegylated interferon beta 1a injection" by Coghe et al.

Multiple sclerosis (Houndmills, Basingstoke, England)·2017
Same author

Open label feasibility study evaluating D-mannose combined with home-based monitoring of suspected urinary tract infections in patients with multiple sclerosis.

Neurourology and urodynamics·2016
Same author

Urinary tract infections in multiple sclerosis.

Multiple sclerosis (Houndmills, Basingstoke, England)·2016

Area of Science:

  • Neurology
  • Pharmacology
  • Healthcare Management

Background:

  • Multiple Sclerosis (MS) treatment has evolved with the introduction of disease-modifying drugs (DMDs).
  • Establishing specialized DMD treatment services is crucial for effective MS patient management.
  • MS nurses play a vital role in the delivery and coordination of DMD therapy.

Purpose of the Study:

  • To describe the evolution and practical management of a DMD treatment service for MS.
  • To provide guidance for MS nurses establishing new DMD clinics.
  • To highlight lessons learned and best practices in DMD service delivery.

Main Methods:

  • Retrospective review of service development and protocols.
  • Description of established best practices in DMD management.

Related Experiment Videos

  • Emphasis on patient partnership and multidisciplinary collaboration.

    • Main Results:

    • Successful establishment and growth of a specialized MS DMD treatment service.
    • Implementation of protocols ensuring best practice in DMD administration and monitoring.
    • Demonstration of the MS nurse's central role in optimizing patient outcomes.

    Conclusions:

    • The development of specialized DMD services is essential for managing MS effectively.
    • Robust protocols, patient-centered care, and multidisciplinary teamwork are key to success.
    • MS nurses are pivotal in delivering high-quality, efficient DMD treatment for multiple sclerosis patients.